Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: a focus on physiology
Yun-Kyeong Cho, Chang-Wook Nam
Korean J Intern Med. 2018;33(5):851-859. Published online 2018 Mar 21 DOI: https://doi.org/10.3904/kjim.2018.006
Citations to this article as recorded by 
The mechanism of influence of kaempferol on proline-rich acidic protein 1 (PRAP1) expression after percutaneous coronary intervention (PCI) was investigated based on sini decoction and siwu decoction
Jingjing Li, Danni Zhu, Weichen Zhang, Songmei Tao, Guanghui Fan
Materials Express.2023; 13(9): 1519. CrossRef
Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services
Yue Lu, Yaqian Wang, Bo Zhou
Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef
Would a Noninvasive Coronary Physiology Become a Standard and Popular Approach?
Yun-Kyeong Cho, Chang-Wook Nam
Korean Circulation Journal.2021; 51(2): 140. CrossRef
SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease
Robert F. Riley, Timothy D. Henry, Ehtisham Mahmud, Ajay J. Kirtane, Emmanouil S. Brilakis, Abhinav Goyal, Cindy L. Grines, William L. Lombardi, Anbukarasi Maran, Tanveer Rab, Jennifer A. Tremmel, Alexander G. Truesdell, Robert W. Yeh, David X. Zhao, Faro
Catheterization and Cardiovascular Interventions.2020; 96(2): 346. CrossRef
Association of coronary artery dominance and mortality rate and complications in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Amir Mikaeilvand, Ata Firuozi, Hosseinali Basiri, Aida Varghaei, Peyman Izadpanah, Javad Kojuri, Alireza Abdi-Ardekani, Armin Attar
Journal of Research in Medical Sciences.2020; 25(1): 107. CrossRef